Itron Stock Price Target and Analyst Ratings (NASDAQ:ITRI)

Analyst Price Target for ITRI

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$97.45

▲ +10.47% Upside Potential

This price target is based on 12 analysts offering 12 month price targets for Itron in the last 3 months. The average price target is $97.45, with a high forecast of $140.00 and a low forecast of $56.00. The average price target represents a 10.47% upside from the last price of $88.22.

Buy

The current consensus among 12 investment analysts is to buy stock in Itron. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
12 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

10/27/2019

0 strong buy ratings
11 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

1/25/2020

0 strong buy ratings
9 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

4/24/2020

0 strong buy ratings
10 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

7/23/2020

0 strong buy ratings
9 buy ratings
0 hold ratings
1 sell ratings

Ratings as of

10/21/2020

0 strong buy ratings
8 buy ratings
0 hold ratings
1 sell ratings

Ratings as of

1/19/2021

0 strong buy ratings
8 buy ratings
0 hold ratings
1 sell ratings

Ratings as of

3/20/2021

0 strong buy ratings
10 buy ratings
1 hold ratings
1 sell ratings

Ratings as of

4/19/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
4/1/2021	JPMorgan Chase & Co.	Initiated Coverage	Overweight	$110.00	Medium	i
4/1/2021	Piper Sandler	Initiated Coverage	Overweight	$120.00	Medium	i
3/31/2021	Morgan Stanley	Initiated Coverage	Equal Weight	$90.00	Medium	i
3/26/2021	JPMorgan Chase & Co.	Initiated Coverage	Overweight	$110.00	High	i
3/26/2021	Piper Sandler	Initiated Coverage	Overweight	$120.00	High	i
3/9/2021	Argus	Upgrade	Hold ➝ Buy	$140.00	High	i
3/3/2021	Oppenheimer	Boost Price Target	Outperform	$75.00 ➝ $127.00	Low	i
3/3/2021	Argus	Upgrade	Hold ➝ Buy	$140.00	Low	i
2/25/2021	Oppenheimer	Boost Price Target	Positive ➝ Outperform	$75.00 ➝ $127.00	Low	i
1/8/2021	Raymond James	Downgrade	Strong-Buy ➝ Outperform	$78.00 ➝ $110.00	High	i
10/15/2020	Stephens	Initiated Coverage	Overweight		Medium	i
9/28/2020	Raymond James	Upgrade	Outperform ➝ Strong-Buy	$78.00	High	i
8/25/2020	Wolfe Research	Initiated Coverage	Underperform	$56.00	Medium	i
8/11/2020	Oppenheimer	Initiated Coverage	Buy	$75.00	Low	i Rating by Noah Kaye at Oppenheimer Holdings Inc.
8/4/2020	Oppenheimer	Lower Price Target	Outperform	$82.00 ➝ $75.00	High	i
8/4/2020	Raymond James	Lower Price Target	Outperform	$82.00 ➝ $78.00	High	i
6/26/2020	Oppenheimer	Lower Price Target	Outperform	$90.00 ➝ $82.00	High	i
6/18/2020	Canaccord Genuity	Reiterated Rating	Buy		Low	i
5/26/2020	Johnson Rice	Initiated Coverage	Buy	$80.00	High	i
5/15/2020	Oppenheimer	Reiterated Rating	Buy	$90.00	Low	i
5/5/2020	JMP Securities	Lower Price Target	Market Outperform	$95.00 ➝ $80.00	High	i
5/5/2020	Cowen	Lower Price Target	Outperform	$88.50 ➝ $78.00	High	i
5/5/2020	Canaccord Genuity	Reiterated Rating	Buy	$81.00	High	i
5/5/2020	Oppenheimer	Reiterated Rating	Buy	$90.00	High	i
3/19/2020	Argus	Downgrade	Buy ➝ Hold		High	i
2/26/2020	Stephens	Lower Price Target	Equal Weight	$96.00 ➝ $83.00	High	i Rating by Robert McCarthy at Stephens
2/25/2020	JMP Securities	Reiterated Rating	Outperform	$95.00	High	i
11/5/2019	Oppenheimer	Boost Price Target		$75.00 ➝ $90.00	Low	i
11/5/2019	Robert W. Baird	Boost Price Target	Outperform	$80.00 ➝ $86.00	High	i Rating by Ben Kallo at Robert W. Baird
10/21/2019	Canaccord Genuity	Boost Price Target	Buy	$77.00 ➝ $87.00	High	i
10/18/2019	Stephens	Set Price Target	Hold	$83.00	Low	i Rating by Robert McCarthy at Stephens
10/1/2019	Raymond James	Boost Price Target	Outperform	$75.00 ➝ $82.00	High	i
9/18/2019	Robert W. Baird	Reiterated Rating	Outperform	$70.00 ➝ $80.00	High	i
8/20/2019	Raymond James	Downgrade	Strong-Buy ➝ Outperform	$75.00	High	i
8/20/2019	Credit Suisse Group	Downgrade	Outperform		High	i
8/16/2019	Argus	Upgrade	Hold ➝ Buy		Medium	i
7/8/2019	Stephens	Initiated Coverage	Equal ➝ Equal Weight	$64.00	Low	i
7/1/2019	Citigroup	Boost Price Target	Outperform	$68.00 ➝ $75.00	High	i
5/7/2019	Oppenheimer	Boost Price Target	Outperform	$60.00 ➝ $68.00	High	i
5/7/2019	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$56.00 ➝ $62.00	High	i
2/28/2019	Cowen	Set Price Target	Buy	$67.00	High	i Rating by Jeff Osborne at Cowen Inc
2/28/2019	JMP Securities	Lower Price Target	Market Outperform ➝ Market Outperform	$80.00 ➝ $72.00	High	i Rating by Joseph Osha at JMP Securities
2/28/2019	Needham & Company LLC	Reiterated Rating	Buy ➝ Buy	$70.00	High	i
1/23/2019	Needham & Company LLC	Lower Price Target	Buy	$75.00	Low	i
12/3/2018	Guggenheim	Initiated Coverage	Buy ➝ Buy	$70.00	High	i Rating by Michael LaMotte at Guggenheim
11/9/2018	Cowen	Reiterated Rating	Buy	$80.00	High	i Rating by Jeff Osborne at Cowen Inc
11/8/2018	Argus	Downgrade	Buy ➝ Hold		Medium	i
11/6/2018	JMP Securities	Set Price Target	Buy	$80.00	High	i Rating by Joseph Osha at JMP Securities
8/22/2018	Argus	Upgrade	Hold ➝ Buy	$72.00	Low	i
8/7/2018	Robert W. Baird	Lower Price Target	Neutral ➝ Neutral	$75.00 ➝ $68.00	High	i
8/7/2018	Oppenheimer	Lower Price Target	Outperform ➝ Outperform	$76.00 ➝ $72.00	High	i
8/6/2018	Guggenheim	Set Price Target	Buy	$73.00	Low	i Rating by Sophie Karp at Guggenheim
8/6/2018	Cowen	Set Price Target	Buy	$80.00	High	i Rating by Jeff Osborne at Cowen Inc
6/6/2018	Canaccord Genuity	Set Price Target	Buy	$84.00	Low	i Rating by Chip Moore at Canaccord Genuity
5/16/2018	Canaccord Genuity	Reiterated Rating	Buy	$84.00	Medium	i Rating by Chip Moore at Canaccord Genuity
4/4/2018	Canaccord Genuity	Reiterated Rating	Buy	$84.00	Low	i Rating by Chip Moore at Canaccord Genuity
3/22/2018	Macquarie	Initiated Coverage	Neutral ➝ Neutral		Medium	i
3/1/2018	JMP Securities	Set Price Target	Market Outperform ➝ Buy	$108.00	Low	i Rating by Joseph Osha at JMP Securities
3/1/2018	Cowen	Upgrade	Market Perform ➝ Outperform	$80.00 ➝ $84.00	Medium	i
2/27/2018	Canaccord Genuity	Upgrade	Hold ➝ Buy	$78.00 ➝ $84.00	Medium	i
1/29/2018	Oppenheimer	Reiterated Rating	Buy	$78.00	Low	i Rating by Noah Kaye at Oppenheimer Holdings Inc.
1/2/2018	Raymond James	Initiated Coverage	Strong-Buy ➝ Strong-Buy	$84.00	Medium	i
1/2/2018	UBS Group	Initiated Coverage	Strong-Buy	$84.00	Medium	i
12/27/2017	Canaccord Genuity	Reiterated Rating	Hold	$78.00	Low	i
11/29/2017	Argus	Downgrade	Buy ➝ Hold		Medium	i
11/3/2017	Needham & Company LLC	Reiterated Rating	Buy	$84.00	N/A	i
10/12/2017	JMP Securities	Set Price Target	Outperform ➝ Buy	$88.00 ➝ $102.00	N/A	i Rating by Joseph Osha at JMP Securities
10/6/2017	Canaccord Genuity	Reiterated Rating	Hold	$78.00	N/A	i
9/19/2017	Canaccord Genuity	Downgrade	Buy ➝ Hold	$78.00	Low	i
9/12/2017	Robert W. Baird	Reiterated Rating	Hold	$77.00	Low	i
9/12/2017	Argus	Reiterated Rating	Buy	$78.00 ➝ $80.00	Low	i
8/4/2017	Oppenheimer	Reiterated Rating	Outperform	$75.00 ➝ $78.00	Low	i Rating by Noah Kaye at Oppenheimer Holdings Inc.
8/3/2017	Needham & Company LLC	Reiterated Rating	Buy	$74.00 ➝ $84.00	Low	i
8/3/2017	Cowen	Set Price Target	Hold	$60.00 ➝ $74.00	High	i Rating by Jeff Osborne at Cowen Inc
7/26/2017	Robert W. Baird	Downgrade	Outperform ➝ Neutral	$73.00 ➝ $77.00	Low	i Rating by Ben Kallo at Robert W. Baird
7/21/2017	Cowen	Set Price Target	Hold	$60.00	Low	i
7/18/2017	JMP Securities	Set Price Target	Buy	$75.00 ➝ $88.00	Medium	i
7/14/2017	Canaccord Genuity	Reiterated Rating	Buy	$78.00	Low	i
7/13/2017	Robert W. Baird	Reiterated Rating	Outperform	$73.00	Low	i Rating by Ben Kallo at Robert W. Baird
6/20/2017	Guggenheim	Initiated Coverage	Buy ➝ Buy	$81.00	Low	i
5/26/2017	Canaccord Genuity	Reiterated Rating	Buy	$72.00	Low	i
3/9/2017	JMP Securities	Initiated Coverage	Mkt Outperform ➝ Outperform	$75.00	Low	i
3/2/2017	Robert W. Baird	Set Price Target	Buy	$73.00	N/A	i Rating by Ben Kallo at Robert W. Baird
3/1/2017	Oppenheimer	Set Price Target	Buy	$70.00	N/A	i Rating by Noah Kaye at Oppenheimer Holdings Inc.
3/1/2017	Needham & Company LLC	Boost Price Target	Buy ➝ Buy	$70.00 ➝ $74.00	N/A	i
12/9/2016	Robert W. Baird	Boost Price Target	Buy	$73.00	N/A	i Rating by ben kallo at Robert W. Baird
12/6/2016	Needham & Company LLC	Reiterated Rating	Buy	$66.00 ➝ $70.00	N/A	i
12/5/2016	Oppenheimer	Set Price Target	Buy	$60.00 ➝ $70.00	N/A	i Rating by Noah Kaye at Oppenheimer Holdings Inc.
12/5/2016	Robert W. Baird	Reiterated Rating	Outperform	$62.00	N/A	i Rating by ben kallo at Robert W. Baird
11/19/2016	Robert W. Baird	Reiterated Rating	Outperform	$62.00	N/A	i Rating by ben kallo at Robert W. Baird
11/14/2016	Needham & Company LLC	Boost Price Target	Buy	$60.00 ➝ $66.00	N/A	i
11/4/2016	Robert W. Baird	Reiterated Rating	Outperform	$62.00	N/A	i Rating by ben kallo at Robert W. Baird
11/3/2016	Oppenheimer	Upgrade	Market Perform ➝ Outperform	$60.00	N/A	i
11/3/2016	UBS Group	Upgrade	Market Perform ➝ Outperform		N/A	i
10/26/2016	Robert W. Baird	Reiterated Rating	Outperform	$56.00 ➝ $62.00	N/A	i Rating by ben kallo at Robert W. Baird
10/3/2016	Canaccord Genuity	Reiterated Rating	Buy	$57.00 ➝ $61.00	N/A	i Rating by John Quealy at Canaccord Genuity
9/4/2016	Robert W. Baird	Set Price Target	Buy	$56.00	N/A	i Rating by ben kallo at Robert W. Baird
9/4/2016	Cowen	Reiterated Rating	Market Perform	$45.00 ➝ $50.00	N/A	i
9/2/2016	Needham & Company LLC	Boost Price Target	Buy	$46.00 ➝ $60.00	N/A	i
9/2/2016	Canaccord Genuity	Reiterated Rating	Buy	$50.00 ➝ $57.00	N/A	i Rating by John Quealy at Canaccord Genuity
8/13/2016	Robert W. Baird	Reiterated Rating	Outperform	$47.00	N/A	i Rating by Ben Kallo at Robert W. Baird
5/4/2016	Canaccord Genuity	Reiterated Rating	Buy		N/A	i Rating by John Quealy at Canaccord Genuity

(Data available from 4/19/2016 forward)

Itron, Inc. is a technology and services company, which engages in the provision of solutions that measure, manage, and analyze energy and water use. It operates through the following segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sensing that do not have communications capability embedded for use with its broader Itron systems. The Networked Solutions segment offers a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution for acquiring and transporting robust application-specific data. The Outcomes segment consist of the firm's value-added, enhanced software and services operating segment in which it manage, organize, analyze, and interpret data to improve decision making, maximize operational profitability, drive resource efficiency, and deliver results for consumers, utilities, and smart cities. The company was founded in 1977 and is headquartered in Liberty Lake, WA.

Today's Range

Now: $88.22

$88.14

$90.72

50 Day Range

MA: $96.65

$83.95

$120.31

52 Week Range

Now: $88.22

$50.87

$122.31

Volume

329,200 shs

Average Volume

604,497 shs

Market Capitalization

$3.98 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Frequently Asked Questions

What sell-side analysts currently cover shares of Itron?

The following sell-side analysts have issued stock ratings on Itron in the last year: Argus, Canaccord Genuity, Cowen Inc, JMP Securities, Johnson Rice, JPMorgan Chase & Co., Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Stephens, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for ITRI.

What is the current price target for Itron?

11 Wall Street analysts have set twelve-month price targets for Itron in the last year. Their average twelve-month price target is $97.45, suggesting a possible upside of 10.5%. Argus has the highest price target set, predicting ITRI will reach $140.00 in the next twelve months. Wolfe Research has the lowest price target set, forecasting a price of $56.00 for Itron in the next year.
View the latest price targets for ITRI.

What is the current consensus analyst rating for Itron?

Itron currently has 1 sell rating, 1 hold rating and 10 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ITRI will outperform the market and that investors should add to their positions of Itron.
View the latest ratings for ITRI.

What other companies compete with Itron?

Other companies that are similar to Itron include Cognex, FLIR Systems, Coherent, National Instruments, Badger Meter, OSI Systems, FARO Technologies, Mesa Laboratories, MTS Systems, Vishay Precision Group and Daktronics.

How do I contact Itron's investor relations team?

Itron's physical mailing address is 2111 N MOLTER ROAD, LIBERTY LAKE WA, 99019. The scientific and technical instruments company's listed phone number is (509) 924-9900 and its investor relations email address is [email protected] The official website for Itron is www.itron.com.

NASDAQ:ITRI - Itron Stock Price Target and Predictions

Analyst Price Target for ITRI

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Itron?

What is the current price target for Itron?

What is the current consensus analyst rating for Itron?

What other companies compete with Itron?

How do I contact Itron's investor relations team?